Daniel Mulville
About Daniel Mulville
Daniel Mulville serves as the Head of Total Rewards at Sana Biotechnology, Inc. He has extensive experience in human resources and executive compensation, having held various roles at Merck and Takeda throughout his career.
Current Role at Sana Biotechnology
Daniel Mulville serves as the Head of Total Rewards at Sana Biotechnology, Inc. since 2021. In this role, he is responsible for overseeing the company's total rewards strategy, which includes compensation, benefits, and employee recognition programs. His work contributes to the overall employee experience and aligns with the company's goals in the biotechnology sector. Sana Biotechnology is located in Cambridge, Massachusetts, where Mulville has been instrumental in shaping the rewards framework.
Previous Experience at Merck
Daniel Mulville has extensive experience at Merck, where he held several key positions. He worked as Manager of HR Shared Services from 2006 to 2009, followed by roles as Associate Director of Global Executive Rewards from 2009 to 2014, and Director of Merck Executive & Broadbase Compensation from 2014 to 2017. His tenure at Merck provided him with a solid foundation in HR policies and management, particularly in the pharmaceuticals industry.
Experience at Takeda
Before joining Sana Biotechnology, Daniel Mulville worked at Takeda as Head of Executive Compensation & Global Equity for one year, from 2019 to 2020. In this capacity, he focused on developing and managing executive compensation strategies and equity programs, further enhancing his expertise in executive pay and compensation structures.
Educational Background in Accounting and Finance
Daniel Mulville earned a Bachelor's degree in Accounting and Finance from Fairleigh Dickinson University, where he studied from 1988 to 1992. This educational background has equipped him with strong financial skills, which he has applied throughout his career in various HR and compensation roles.
Skills and Expertise
Daniel Mulville possesses strong skills in HR policies and management, with a particular focus on executive pay and mergers & acquisitions (M&A). His extensive experience in the pharmaceuticals industry has allowed him to develop a comprehensive understanding of compensation strategies and their impact on organizational success.